Ipamorelin is a synthetic peptide studied as a growth hormone secretagogue: a compound that stimulates growth hormone release through the ghrelin receptor pathway. Laboratory and human research have examined its effects on growth hormone signalling.
In simple terms: researchers study ipamorelin to understand how ghrelin-related signals trigger growth hormone release.
Product Details
| Component | Details |
|---|---|
| Compound | Ipamorelin |
| Research category | Ghrelin receptor and growth hormone signalling |
| Vial strength | As stated on the selected product listing |
What Is Ipamorelin Studied For?
Preclinical and laboratory research only
Growth hormone release: Studies have measured growth hormone responses after exposure to ipamorelin in pituitary cell models and human volunteers.
Ghrelin receptor signalling: Researchers investigate how ipamorelin activates the growth hormone secretagogue receptor, a pathway distinct from the GHRH receptor pathway.
Hormone-response selectivity: Early research compared ipamorelin’s effects on growth hormone with other pituitary hormone responses.
Research Use Notice
FOR RESEARCH PURPOSES ONLY. This product is intended for laboratory research and is not offered for human or veterinary use. It is not intended for therapeutic or diagnostic purposes. By purchasing, the customer acknowledges that this product is for research use only and assumes responsibility for its use.
